Literature DB >> 16300270

Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment.

Hidetomo Nakamoto1.   

Abstract

Encapsulating peritoneal sclerosis (EPS) is recognized as a serious complication of continuous peritoneal dialysis. A preliminary diagnosis of EPSis usually based on clinical signs and symptoms, which commonly include abdominal pain, nausea, vomiting, anorexia, abdominal fullness, an abdominal mass, bowel obstruction, and radiologic findings, including abdominal roentgenogram, contrast studies, ultrasound studies, and computed tomography. The diagnosis is confirmed by laparoscopy or laparotomy showing the characteristic gross thickening of the peritoneum enclosing some or all of the small intestine in a cocoon of opaque tissue. A variety of therapeutic approaches to EPS have been reported. This review discusses medical treatment of EPS and includes an overview of the clinical features and diagnostic aspects of the condition.

Entities:  

Mesh:

Year:  2005        PMID: 16300270

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  58 in total

1.  Idiopathic sclerosing encapsulating peritonitis in an adult male with intermittent subacute bowel obstruction, preoperative multidetector-row CT (MDCT) diagnosis.

Authors:  Rakesh Kumar Gupta; Agrawal Shekhar Chandra; Amir Bajracharya; Panna Lal Sah
Journal:  BMJ Case Rep       Date:  2011-08-29

2.  Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis.

Authors:  Tatsuhiro Yaginuma; Izumi Yamamoto; Hiroyasu Yamamoto; Jun Mitome; Yudo Tanno; Keitaro Yokoyama; Takenori Hayashi; Tetsuya Kobayashi; Michiaki Watanabe; Yutaka Yamaguchi; Tatsuo Hosoya
Journal:  Perit Dial Int       Date:  2012-06-01       Impact factor: 1.756

3.  Idiopathic encapsulating sclerosing peritonitis.

Authors:  Turan Acar; İbrahim Kokulu; Nihan Acar; Cengiz Tavusbay; Mehmet Hacıyanlı
Journal:  Ulus Cerrahi Derg       Date:  2015-07-10

4.  Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon): a report of 5 cases.

Authors:  Ping Xu; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

Review 5.  Idiopathic sclerosing encapsulating peritonitis: abdominal cocoon.

Authors:  Jenny N Tannoury; Bassam N Abboud
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

Review 6.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

7.  Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model.

Authors:  Latife Bircan; Suleyman Karakose; Hatice Unverdi; Ayşe Zeynep Bal; Selman Unverdi; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2017-02-11       Impact factor: 2.370

8.  The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

Authors:  Bülent Huddam; Murat Başaran; Gülay Koçak; Alper Azak; Funda Yalçın; Nihan Haberal Reyhan; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2015-07-10       Impact factor: 2.370

9.  Peritoneal Dialysis-Associated Peritonitis Caused by Mycobacterium abscessus.

Authors:  Tsung-Kun Yang; Jia-Jung Lee; Po-Liang Lu; Hung-Tien Kuo; Mei-Chuan Kuo; Hung-Chun Chen
Journal:  Perit Dial Int       Date:  2015 May-Jun       Impact factor: 1.756

10.  Can EPS development be avoided with early interventions? The potential role of tamoxifen--a single-center study.

Authors:  Erika De Sousa-Amorim; Gloria Del Peso; M Auxiliadora Bajo; Laura Alvarez; Marta Ossorio; Fernando Gil; Teresa Bellon; Rafael Selgas
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.